P
Patrick Dufour
Researcher at University of Strasbourg
Publications - 107
Citations - 2874
Patrick Dufour is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Cancer & Chemotherapy. The author has an hindex of 28, co-authored 102 publications receiving 2728 citations.
Papers
More filters
Journal ArticleDOI
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.
Hiroshi Nakano,Elie Oussoultzoglou,Edoardo Rosso,Selenia Casnedi,Marie-Pierre Chenard-Neu,Patrick Dufour,Philippe Bachellier,Daniel Jaeck +7 more
TL;DR: The present study suggests that SI resulted in a poorer liver functional reserve and in a higher complication rate after major hepatectomy, and female patients who received 6 cycles or more of OBC, or presenting with abnormal preoperative aspartate aminotransferase and ICG-R15 values should be carefully selected before deciding to undertake a major hepATEctomy.
Journal ArticleDOI
Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.
Raoul Herbrecht,Valérie Letscher-Bru,Corina Oprea,Bruno Lioure,J. Waller,Odile Villard,Kun-Lun Liu,Shanti Natarajan-Amé,Patrick Lutz,Patrick Dufour,Jean-Pierre Bergerat,Ermanno Candolfi +11 more
TL;DR: Galactomannan ELISA seems less sensitive than previously described, and sensitivity can be further reduced by the presence of anti-Aspergillus antibodies.
Journal ArticleDOI
Frequent factor II G20210A mutation in idiopathic portal vein thrombosis
P. Chamouard,Erwan Pencreach,Frédéric Maloisel,Lelia Grunebaum,Jean-Francois Ardizzone,Alice Meyer,Marie-Pierre Gaub,Joëlle Goetz,René Baumann,Béatrice Uring-Lambert,Salomon Levy,Patrick Dufour,Georges Hauptmann,Pierre Oudet +13 more
TL;DR: The frequency of factor II G20210A mutation is frequent in patients with idiopathic portal vein thrombosis and should be assessed under this circumstance and was assessed in this study.
Journal ArticleDOI
Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
Frédéric Maloisel,Emmanuel Andrès,Jacques Zimmer,Esther Noel,Alina Zamfir,Argyro Koumarianou,Patrick Dufour +6 more
TL;DR: In this article, the authors studied whether danazol, an attenuated androgen, is useful in the management of refractory chronic idiopathic thrombocytopenic purpura.
Journal ArticleDOI
Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience With 118 Patients
TL;DR: In a specialized setting, P-AR for locally advanced pancreatic adenocarcinoma can be performed safely with limited mortality and morbidity and negative resection margin and the absence of associated venous invasion might predict favorable long-term outcomes.